Risperidone

Risperidone Reactions 1704, p332 - 2 Jun 2018 Various toxicities: case report A 62-year-old woman developed sedation, dyskinesia of the right upper extremity, hemiballism and akathisia following treatment with risperidone [time to reaction onset not stated; not all outcomes stated]. The woman, who was bed redden for ten months, suddenly walked up to the nursing station. She had been receiving treatment with oral risperidone 0.5mg twice a day as needed, which was prescribed by the previous nursing station to manage her aggression and agitation. The risperidone treatment was stopped a day prior to the event. She had a history of behaviour disturbance, dementia with psychosis, dysphagia and aphasia. The physical examination showed dyskinesia of the right upper extremity, hemiballism, and akathisia. She did not follow commands, was not oriented to person place or time and was unable to speak, but was alert. It was considered that the sedation and the non-ambulatory condition was secondary to the risperidone therapy. Author comment: "Additional side effects include mild sedation, EEG abnormalities, orthostatic hypotension, EPS, tardive dyskinesia". "Risperidone increases in concentration, at higher doses, in an age-dependent manner, and has a half-life of 20 to 22 hours; this may partially explain why the patient experienced sedation, but started walking shortly after discontinuing the medication." Lwanga A, et al. "She can walk". Miracles happen when we de-prescribe. Journal of the American Geriatrics Society 66 (Suppl. 2): S16 abstr. A13, Apr 2018. Available from: URL: http://doi.org/10.1111/jgs.15376 [abstract] - USA 803323473 0114-9954/18/1704-0001/$14.95 Adis © 2018 Springer International Publishing AG. All rights reserved Reactions 2 Jun 2018 No. 1704 http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png Reactions Weekly Springer Journals

Risperidone

Reactions Weekly , Volume 1704 (1) – Jun 2, 2018
Free
1 page
Loading next page...
1 Page
 
/lp/springer_journal/risperidone-zL5jMKlSW0
Publisher
Springer International Publishing
Copyright
Copyright © 2018 by Springer International Publishing AG, part of Springer Nature
Subject
Medicine & Public Health; Drug Safety and Pharmacovigilance; Pharmacology/Toxicology
ISSN
0114-9954
eISSN
1179-2051
D.O.I.
10.1007/s40278-018-46975-z
Publisher site
See Article on Publisher Site

Abstract

Reactions 1704, p332 - 2 Jun 2018 Various toxicities: case report A 62-year-old woman developed sedation, dyskinesia of the right upper extremity, hemiballism and akathisia following treatment with risperidone [time to reaction onset not stated; not all outcomes stated]. The woman, who was bed redden for ten months, suddenly walked up to the nursing station. She had been receiving treatment with oral risperidone 0.5mg twice a day as needed, which was prescribed by the previous nursing station to manage her aggression and agitation. The risperidone treatment was stopped a day prior to the event. She had a history of behaviour disturbance, dementia with psychosis, dysphagia and aphasia. The physical examination showed dyskinesia of the right upper extremity, hemiballism, and akathisia. She did not follow commands, was not oriented to person place or time and was unable to speak, but was alert. It was considered that the sedation and the non-ambulatory condition was secondary to the risperidone therapy. Author comment: "Additional side effects include mild sedation, EEG abnormalities, orthostatic hypotension, EPS, tardive dyskinesia". "Risperidone increases in concentration, at higher doses, in an age-dependent manner, and has a half-life of 20 to 22 hours; this may partially explain why the patient experienced sedation, but started walking shortly after discontinuing the medication." Lwanga A, et al. "She can walk". Miracles happen when we de-prescribe. Journal of the American Geriatrics Society 66 (Suppl. 2): S16 abstr. A13, Apr 2018. Available from: URL: http://doi.org/10.1111/jgs.15376 [abstract] - USA 803323473 0114-9954/18/1704-0001/$14.95 Adis © 2018 Springer International Publishing AG. All rights reserved Reactions 2 Jun 2018 No. 1704

Journal

Reactions WeeklySpringer Journals

Published: Jun 2, 2018

There are no references for this article.

You’re reading a free preview. Subscribe to read the entire article.


DeepDyve is your
personal research library

It’s your single place to instantly
discover and read the research
that matters to you.

Enjoy affordable access to
over 18 million articles from more than
15,000 peer-reviewed journals.

All for just $49/month

Explore the DeepDyve Library

Search

Query the DeepDyve database, plus search all of PubMed and Google Scholar seamlessly

Organize

Save any article or search result from DeepDyve, PubMed, and Google Scholar... all in one place.

Access

Get unlimited, online access to over 18 million full-text articles from more than 15,000 scientific journals.

Your journals are on DeepDyve

Read from thousands of the leading scholarly journals from SpringerNature, Elsevier, Wiley-Blackwell, Oxford University Press and more.

All the latest content is available, no embargo periods.

See the journals in your area

DeepDyve

Freelancer

DeepDyve

Pro

Price

FREE

$49/month
$360/year

Save searches from
Google Scholar,
PubMed

Create lists to
organize your research

Export lists, citations

Read DeepDyve articles

Abstract access only

Unlimited access to over
18 million full-text articles

Print

20 pages / month

PDF Discount

20% off